Work

A Multi-modal Approach to Evaluate the Impact of Risk Evaluation and Mitigation Strategy (REMS) Programs

Year: 2021

Type: article

Study design: Study Protocol

Source: Drug Safety

DOI: 10.1007/s40264-021-01070-2

Authors: Ameet Sarpatwari, Mayookha Mitra-Majumdar, Katsiaryna Bykov, Jerry Avorn, Steven Woloshin, Gita A. Toyserkani, Cynthia LaCivita, Claudia Manzo, Esther H. Zhou, Ellen Pinnow, Gerald J. Dal Pan, Joshua J. Gagne, Krista F. Huybrechts, William B. Feldman, Kristyn Chin, Aaron S. Kesselheim

Institutions: Brigham and Women's Hospital, Harvard University, Dartmouth Institute for Health Policy and Clinical Practice, United States Food and Drug Administration, Center for Drug Evaluation and Research

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Arnold Ventures, U.S. Food and Drug Administration, National Heart, Lung, and Blood Institute

Awards: G2746318747, Integrated Training in Respiratory Research

OpenAlex ID: W3158677318

FWCI: 1.464

Cites: 18

Cited by: 14

Related to: 10